Variants conferring risk of atrial fibrillation on chromosome 4q25
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia in humans and is characterized by chaotic electrical activity of the atria. It affects one in ten individuals over the age of 80 years, causes significant morbidity and is an independent predictor of mortality. Recent studies have provided evidence of a genetic contribution to AF. Mutations in potassium-channel genes have been associated with familial AF but account for only a small fraction of all cases of AF. We have performed a genome-wide association scan, followed by replication studies in three populations of European descent and a Chinese population from Hong Kong and find a strong association between two sequence variants on chromosome 4q25 and AF. Here we show that about 35% of individuals of European descent have at least one of the variants and that the risk of AF increases by 1.72 and 1.39 per copy. The association with the stronger variant is replicated in the Chinese population, where it is carried by 75% of individuals and the risk of AF is increased by 1.42 per copy. A stronger association was observed in individuals with typical atrial flutter. Both variants are adjacent to PITX2, which is known to have a critical function in left-right asymmetry of the heart.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These biobank efforts, pioneered in studies such as the Framingham Cohort70 and the efforts of DeCODE in Iceland71,72, now encompass a growing inventory of national cohorts in North America, Europe, Asia and beyond73–76.”
From A brief history of human disease genetics (2020) · cites this paper as [71]
In the citing paper
“The most important variants are located close to the paired-like homeodomain transcription factor 2 gene on chromosome 4q25.63,64”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [63]
In the citing paper
“The AF-GRS comprised 12 SNPs that had been previously shown to be associated with AF at genome-wide significance.”
From Twelve-single nucleotide polymorphism genetic risk score identifies individuals at increased risk for future atrial fibrillation and stroke (2014) · cites this paper as [18]
In the citing paper
“These are all the SNPs that have been reported to be associated with AF at a genome-wide significance level (P<5×10−8), including 4 SNPs at PITX2 locus.18-23”
From Twelve-single nucleotide polymorphism genetic risk score identifies individuals at increased risk for future atrial fibrillation and stroke (2014) · cites this paper as [18]
Citations
Cites
Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease
(1959) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/22.4.719 · Cited by 14,689
Go, A. S., Hylek, E. M., Phillips, K. A., Chang, Y., Henault, L. E., Selby, J. V., & Singer, D. E. (2001) · JAMA · doi:10.1001/jama.285.18.2370 · Cited by 6,205
A haplotype map of the human genome
The International HapMap Consortium (2005) · Nature · doi:10.1038/nature04226 · Cited by 5,858
Miyasaka, Y., Barnes, M. E., Gersh, B. J., Cha, S. S., Bailey, K. R., Abhayaratna, W. P., Seward, J. B., & Tsang, T. S. M. (2006) · Circulation · doi:10.1161/circulationaha.105.595140 · Cited by 2,564
Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes
Grant, S. F. A., Thorleifsson, G., Reynisdottir, I., Benediktsson, R., Manolescu, A., Sainz, J., Helgason, A., Stefansson, H., Emilsson, V., Helgadottir, A., et al. (2006) · Nature Genetics · doi:10.1038/ng1732 · Cited by 2,287
Self-citationKCNQ1 Gain-of-Function Mutation in Familial Atrial Fibrillation
Chen, Y.-H., Xu, S.-J., Bendahhou, S., Wang, X.-L., Wang, Y., Xu, W.-Y., Jin, H.-W., Sun, H., Su, X.-Y., Zhuang, Q.-N., et al. (2003) · Science · doi:10.1126/science.1077771 · Cited by 1,000
FALK, C. T., & RUBINSTEIN, P. (1987) · Annals of Human Genetics · doi:10.1111/j.1469-1809.1987.tb00875.x · Cited by 614
Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring
Fox, C. S. (2004) · JAMA · doi:10.1001/jama.291.23.2851 · Cited by 600
The gene encoding phosphodiesterase 4D confers risk of ischemic stroke
Gretarsdottir, S., Thorleifsson, G., Reynisdottir, S. T., Manolescu, A., Jonsdottir, S., Jonsdottir, T., Gudmundsdottir, T., Bjarnadottir, S. M., Einarsson, O. B., Gudjonsdottir, H. M., et al. (2003) · Nature Genetics · doi:10.1038/ng1245 · Cited by 564
Self-citationKv1.5 channelopathy due to KCNA5 loss-of-function mutation causes human atrial fibrillation
Olson, T. M., Alekseev, A. E., Liu, X. K., Park, S., Zingman, L. V., Bienengraeber, M., Sattiraju, S., Ballew, J. D., Jahangir, A., & Terzic, A. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl143 · Cited by 491
Cited by
Items 801–900 of 949
Liew, R. (2012) · Український кардіологічний журнал
Arrhythmias Due to Monogenic Disorders
Darbar, D., Kannankeril, P. J., & Roden, D. M. (2009) · Wiley eBooks · doi:10.1002/9781444309768.ch44
Martín‐Garcia, A. (2012) · Gredos (University of Salamanca) · doi:10.14201/gredos.121193
Estudios de asociación mediante rastreo genómico y su contribución en la genética del asma
Chávez, Y. A., & Martínez, B. (2010) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Active Supraventricular Arrhythmias
de Luna, A. B. (2011) · Wiley eBooks · doi:10.1002/9781444391749.ch4
de Luna, A. D. (2012) · Wiley eBooks · doi:10.1002/9781118392041.ch21
Genetics of Obstructive Sleep Apnea
Helgadottir, H. T. (2013)
Chamberlain, A. M. (2009) · University of Minnesota Digital Conservancy (University of Minnesota)
Genetic factors involved in stroke susceptibility and in outcome at three months
Manso, H. (2011) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Taking Advantage of New Tools and Techniques
Olsen, L., & McGinnis, J. M. (2010)
Population-based prediction of atrial fibrillation
Smith, G. J. (2012) · Lund University Publications (Lund University)
Deciphering Cardiovascular Genomics and How They Apply to Cardiovascular Disease Prevention
Musunuru, K. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-963-5_6
“locus contributes to myocardial infarction.) Other studies have identified SNPs associated with atrial fibrillation ( 5 ), lipid levels (6–9), diabetes mellitus (10–12), electrocardiographic QT interval (13), abdominal aortic aneurysm (14), and statin-induced myopathy (15).”
BackgroundMedicina personalizada en enfermedades cardiovasculares
Peris, F.-J. G. (2010) · Elsevier eBooks · doi:10.1016/b978-84-458-2025-4.00009-7
Génétique de la fibrillation auriculaire
Marec, H. L., & Probst, V. (2009) · Annales de Cardiologie et d Angéiologie · doi:10.1016/s0003-3928(09)73407-9
Électrophysiologie de la fibrillation atriale
Hatem, S. N. (2013) · Archives of Cardiovascular Diseases Supplements · doi:10.1016/s1878-6480(13)70885-1 · Cited by 2
Improving the Prediction of Incident Atrial Fibrillation—Reply
Schnabel, R. B. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.267
Furukawa, T., & Ebana, Y. (2012) · Journal of Arrhythmia · doi:10.1016/j.joa.2012.04.004 · Cited by 2
Vorhofflimmern und Blutungskomplikationen: Risikofaktoren und -marker
Ravens, U., Kirchhof, P. F., Gelder, I. C. V., & Breithardt, G. (2012) · Nervenheilkunde · doi:10.1055/s-0038-1628223
Pharmacological and Biological Risk Factors for Cardiac Arrhythmias
van Noord, C. (2009)
Chang, S.-H., Chang, S., Lin, L., Lai, L., Tseng, C.-D., Wang, Y., Yu, C., Chiang, F., Hwang, J., Lin, J., et al. (2014) · Europe PMC (PubMed Central)
Liew, R. (2011) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2011.11.001
Ictus isquémico: avances y proyecciones
García, P. L. R. (2014) · Revista cubana de neurología y neurocirugía · Cited by 6
Molecular and clinical markers in ischaemic cerebrovascular disease
Markaki, I. (2013) · Figshare
Predicting atrial fi brillation
Schnabel, R. B. (2009)
Beleslin, B., Deljanin, M., Kanjuh, V., Parapid, B. J., Giga, V. L., Prostran, M. S., Angelkov, L., Balinovac, J., Bikicki, M., Ambrosio, G., et al. (2013)
How Can We Avoid a Stroke Crisis in Europe
Andreotti, F., Camm, A. J., & Lobban, T. (2012)
Meschia, J. F., Moore, W. S., Pearson, T. A., Hart, R. G., Hinchey, J. A., Howard, V. J., Jauch, E. C., Chaturvedi, S., Creager, M. A., Culebras, A., et al. (2010)
Schork, N. J., Malo, N., & Topol, E. J. (2008)
Novel Molecular Mechanisms in the Pathophysiology of Human Atrial Fibrillation
Alzoughool, F. (2015) · uO Research (University of Ottawa) · doi:10.20381/ruor-887
Febres‐Aldana, C. A., Fernandez‐Ruiz, R., Febres-Aldana, A. J., & Martínez, A. D. (2015) · Insuficiencia cardíaca
Meschia, J. F., & Woo, D. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-5478-8.10018-1
Liew, R. (2012) · The Egyptian Heart Journal · doi:10.1016/j.ehj.2012.02.007
Inherited arrhythmias in children.
Balaji, S. (2008) · PubMed Central
Pharmacogenomics of Cardiac Arrhythmias
Roden, D. M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-44733-1.00055-9
The Path to Personalized Cardiovascular Medicine
Marín-García, J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-404599-6.00024-x
New Antiarrhythmic Drugs and New Concepts for Old Drugs
Kirchhof, P. F. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-2856-5.00112-6
Genetic Mechanisms of Arrhythmia
Priori, S. G., Napolitano, C., & MacRae, C. A. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-381510-1.00042-9
Self-citationGenomics in Atrial Fibrillation: A Brief Review
Deshmukh, A. J. (2014) · Journal of Molecular and Genetic Medicine · doi:10.4172/1747-0862.1000114
Molecular genetics of atherosclerosis and acute coronary syndromes
Damani, S. B., & Topol, E. J. (2011) · Elsevier eBooks · doi:10.1016/b978-0-7295-3927-2.10006-5
Study Design and Statistical Issues in Pharmacogenetics Research
Schork, N. J., Malo, N., & Topol, E. J. (2008) · Methods in pharmacology and toxicology · doi:10.1007/978-1-59745-439-1_9
Genetics and Genomics of Arrhythmias
Towbin, J., & Vatta, M. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374934-5.00029-5
Chiuve, S. E., Albert, C. M., & Conen, D. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-384978-6.00068-6
Atrial Fibrillation: Epidemiology and Demographics
Soto‐Ruiz, K. M. (2016) · Contemporary cardiology · doi:10.1007/978-3-319-31386-3_1
Toward Translation of Genomic Discovery to Clinical Efficacy in Atrial Fibrillation ∗
Gollob, M. H. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.08.022
“Using this approach, in 2007 the deCODE genetics group from Iceland reported the first SNPs to be found more commonly in persons with AF as compared with controls without AF (3).”
MethodInvestigation of the mechanisms mediating genetic associations with atrial fibrillation
Martin, R. I. R. (2015)
The mechanism of progression to chronic AF : From the prospect of recent genomic research
Furukawa, T. (2016) · Japanese Journal of Electrocardiology · doi:10.5105/jse.36.167
Innovations in Antiarrhythmic Drug Therapy
Kirchhof, P. F., & Fabritz, L. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-44733-1.00113-9
Running title: Shoemaker et al.; Genetic Variants and Response to AF Ablation
Shoemaker, M. B., Bollmann, A., Lubitz, S. A., Ueberham, L., Saini, H. S., Montgomery, J. A., Edwards, T. L., Yoneda, Z. T., Sinner, M. F., Arya, A., et al. (2017)
Self-citationOBSOLETE: Pharmacogenomics of Antiarrhythmic Drug Therapy for Atrial Fibrillation
Darbar, D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.99763-0
OBSOLETE: Genetic Atrial Fibrillation
Darbar, D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.99761-7
Ohno, S., & Horie, M. (2017) · Springer eBooks · doi:10.1007/978-981-10-3379-7_3
Genomics of Cardiac Arrhythmias
Roden, D. M., & Shoemaker, M. B. (2017) · Cardiovascular medicine · doi:10.1007/978-3-319-58000-5_3
On the road to atrial fibrillation
Sorajja, D., & Shen, W.-K. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.09.041
“The fact that blacks have more traditional risk factors, such as heart failure, hypertension, and diabetes, yet have less AF suggests that race, genetics, or other factors may modulate the risk of AF.13 Part of the explanation may be European ancestry, which in incremental amounts carries increased risk of AF.13 Genom…”
BackgroundInfluentialInherited Conduction Disease and Atrial Fibrillation
Martin, C., & Lambiase, P. D. (2018) · Springer eBooks · doi:10.1007/978-3-319-66114-8_15
Giraldo, M., & Alejandro, P. (2017) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Anthropometric and genetic determinants of cardiac morphology and function
de Marvao, A. (2015) · Spiral (Imperial College London) · doi:10.25560/56050
Sinner, M. F., Clauß, S., & Kääb, S. (2018) · Aktuelle Kardiologie · doi:10.1055/s-0037-1599557 · Cited by 1
Cardiac looping and laterality
Campione, M., Aránega, A. E., & Franco, D. (2018) · Oxford University Press eBooks · doi:10.1093/med/9780198757269.003.0014 · Cited by 2
Gene Therapy and Genomic Application in Heart Disease
Zhu, F., & Huang, K. (2018) · Translational bioinformatics · doi:10.1007/978-981-13-1429-2_13
Progress of Genomics in Cardiac Conduction and Rhythm Disorders
Xu, Z., Xiong, Q., Shen, Y., Hu, J., & Hong, K. (2018) · Translational bioinformatics · doi:10.1007/978-981-13-1429-2_9
Ménage à trois: single-nucleotide polymorphisms, calcium and atrial fibrillation
Schneider‐Warme, F., & Ravens, U. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy283
Ethnicity and Atrial Fibrillation: A Counterintuitive Phenomenon
Colella, A., & Modesti, P. A. (2018) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-319-93148-7_10
Genetics of Atrial Fibrillation
Lubitz, S. A., & Ellinor, P. T. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-44733-1.00049-3
Self-citationNeháj, F., Sokol, J., Kubašková, M., Mokáň, M., Chudej, J., Péč, M. J., Mokáň, M., Galajda, P., & Michalová, R. (2019) · Interní medicína pro praxi · doi:10.36290/int.2019.043
Podgoreanu, M. V. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-382227-7.00055-0
New Stroke Prophylaxis Options in Atrial Fibrillation Patients.
Thomas, G., & Lerman, B. B. (2013) · Europe PMC (PubMed Central) · doi:10.4022/jafib.462
CHAPTER 62 – Genetics and Genomics of Arrhythmias
Towbin, J., & Vatta, M. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-369420-1.00062-7
Pharmacogenomics of Cardiac Arrhythmias
Roden, D. M. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-2856-5.00055-8
Selzman, K. A. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/qns9-yb38
Gunawan, M. G. (2019) · Summit (Simon Fraser University)
Kurbanov, R. D., Абдуллаева, Г. Ж., Ganiev, T. Z., Abdullaev, A. A., & Закиров, Н. У. (2020) · Eurasian heart journal · doi:10.38109/2225-1685-2020-4-30-37
Non-atrial fibrillation cardiac phenotypes associated with common atrial fibrillation genotypic riskPreprint
Kapur, S. V., Beik, S. P., Gillon, L., & MacRae, C. A. (2020) · Authorea · doi:10.22541/au.160808321.12807243/v1
Self-citationÞórisson, G. Á. (2011) · OpenGrey (Institut de l'Information Scientifique et Technique)
Alalwan, M. A., Al-Ohaid, F., Alhajjaj, H. M., Hazeem, A. A., AlJulaih, G. H., Al-Khedher, R., Alshehri, A., & Jatoi, N.-A. (2021) · Cureus · doi:10.7759/cureus.12493
“Multiple lines of evidence demonstrate a common genetic predisposition since the early 1930s, the first GWAS (genome-wide association study) that was done on an Icelandic population, 550 AF patients and 4476 controls in 2007, detected an association between variants at chromosome 4q25 and AF susceptibility, but the me…”
BackgroundThe pervasive role of microRNAs in arrhythmia: animal models and novel discoveries
Guzzolino, E., & Pitto, L. (2019) · Journal of Translational Science · doi:10.15761/jts.1000296
Association of polymorphisms of chromosome 4q25 in patients with atrial fibrillation
Va, S., Nikulina, S. Y., Poplavskaya, E. E., Maksimov, V. N., Aksyutina, N. V., & Nazarov, B. V. (2016) · Cardiosomatics · doi:10.26442/cs45213
Ложкина, Н. Г., Гуражева, А. А., & Maksimov, V. N. (2021) · Медико-фармацевтический журнал «Пульс» · doi:10.26787/nydha-2686-6838-2021-23-2-42-52
Prevention of atrial fibrillation – non-modifiable and modifiable risk factors for AF
Wojdyła‐Hordyńska, A., & Hordyński, G. (2020) · In a good rythm · doi:10.5604/01.3001.0014.2845
Will patient’s genetic profile help to choose treatment method of atrial fibrillation?
Fuglewicz, A. (2019) · In a good rythm · doi:10.5604/01.3001.0013.7384
Victorino, J., Rollán, I., Rouco, R., Adan, J., & Manzanares, M. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.07.14.452222
“Variants within the first intron of ZFHX3 at the 16q22 locus have been associated to AF since the very first genetic reports more than a decade ago (20, 21), but we still lack functional evidence that ZFHX3 or other genes are regulated by the 16q22 AF-risk locus (75).”
BackgroundA Molecular Genetic Perspective on Atrial Fibrillation
Roberts, J. D., & Gollob, M. H. (2010) · Springer eBooks · doi:10.1007/978-1-84996-471-5_13
Correction to: Epigenetic and Transcriptional Networks Underlying Atrial Fibrillation
(2020) · Circulation Research · doi:10.1161/res.0000000000000429
Identification of Atrial Fibrillation Risk Variant RS2200733 In Indian Young Adult PopulationPreprint
Manoharan, A., Ravikumar, S., Sathish, V., & Bhat, V. B. (2021) · Research Square · doi:10.21203/rs.3.rs-993249/v1
Active Supraventricular Arrhythmias
de Luna, A. B., & FCCS, A. B. M. F. F. (2017) · Wiley eBooks · doi:10.1002/9781119212782.ch4
Lin, L. Y., Barszczewski, T., Burgon, P. G., & Tibbits, G. F. (2022) · Springer eBooks · doi:10.1007/978-981-16-6016-0_44-1
de Luna, A. B., & FCCS, A. B. M. F. F. (2017) · Wiley eBooks · doi:10.1002/9781119212782.ch9
Rahm, A., Katus, H. A., & Thomas, D. (2018) · Cardiac and vascular biology · doi:10.1007/978-3-319-77812-9_12
Gomes, J. A. (2020) · Springer eBooks · doi:10.1007/978-3-030-45066-3_11
de Luna, A. B. (2011) · Wiley eBooks · doi:10.1002/9781444391749.ch9
A Molecular Genetic Perspective on Atrial Fibrillation
Roberts, J. D., & Gollob, M. H. (2020) · Springer eBooks · doi:10.1007/978-3-030-45457-9_18
The year in arrhythmias 2007: Part II
Josephson, M. E., Rosen, M. R., & Tomaselli, G. F. (2008) · Heart Rhythm · doi:10.1016/j.hrthm.2008.03.013
“Sequence variants at 4q25 in 3 poplations of European descent and a Chinese population have een associated with AF.(3) Another genome-wide associaion study in the Framingham cohort has identified a single ucleotide polymorphism on chromosome 13 associated ith AF.”
BackgroundPharmacogenomics of Antiarrhythmic Drug Therapy for Atrial Fibrillation
Darbar, D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809657-4.99763-1
直昌, 蒔. (2013) · Journal of JCS Cardiologists · doi:10.1253/jjcsc.21.1_3
Campuzano, Ó., & Brugada, R. (2009) · Springer eBooks · doi:10.1007/978-1-84882-927-5_14
PITX2 (Pituitary Homeobox Gene 2)
Franco, D., & Aránega, A. E. (2016) · Springer eBooks · doi:10.1007/978-1-4614-6438-9_101670-1
Lau, G. K. K., Pendlebury, S. T., & Rothwell, P. M. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316161609.004
Metadata
- Authors
- Gudbjartsson, D. F., Arnar, D. O., Helgadottir, A., Gretarsdottir, S., Holm, H., Sigurdsson, A., Jonasdottir, A., Baker, A., Thorleifsson, G., Kristjansson, K., Palsson, A., Blondal, T., Sulem, P., Backman, V. M., Hardarson, G. A., Palsdottir, E., Helgason, A., Sigurjonsdottir, R., Sverrisson, J. T., Kostulas, K., Ng, M. C. Y., Baum, L., So, W. Y., Wong, K. S., Chan, J. C. N., Furie, K. L., Greenberg, S. M., Sale, M., Kelly, P., MacRae, C. A., Smith, E. E., Rosand, J., Hillert, J., Ma, R. C. W., Ellinor, P. T., Thorgeirsson, G., Gulcher, J. R., Kong, A., Thorsteinsdottir, U., & Stefansson, K.
- Affiliations
- deCODE Genetics (Iceland) (IS)
- Karolinska University Hospital (SE)
- Chinese University of Hong Kong (HK)
- Harvard University (US)
- Corresponding author
- Gudbjartsson, Daniel F.
- ORCID
- Venue
- Nature
- Published
- 2007-07
- Volume
- 448
- Issue
- 7151
- Pages
- 353-357
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2037988353
- Cited by
- 955
- References
- 24
- Citations by year
- 2026: 23 · 2025: 23 · 2024: 36 · 2023: 38 · 2022: 32 · 2021: 32 · 2020: 48 · 2019: 39 · 2018: 53 · 2017: 68 · 2016: 63 · 2015: 48 · 2014: 59 · 2013: 68 · 2012: 67
- FWCI
- 43.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Hirsla (Landspítali University Hospital) (submittedVersion)
- Funders
- Massachusetts General Hospital
- Landspítali Háskólasjúkrahús
- National Heart, Lung, and Blood Institute (R01HL075431)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- atrial fibrillation, chromosome 4q25, PITX2, genetic risk factors, cardiac arrhythmias, atrial flutter, heart development, genetic association, Chinese population, European populations
- MeSH terms
- Aged, Aged, 80 and over, Atrial Fibrillation, Chromosomes, Human, Pair 4, Female, Gene Frequency, Haplotypes, Hong Kong, Humans, Iceland, Male, Middle Aged, Sweden, United States, Genetic Variation, Genome, Human, Age Distribution, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, White People, Asian People
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.